Vaccine Vials Market Research Report by Type (Multi Dose and Single Dose), by Material (Glass and Polymer), by Capacity, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Vaccine Vials Market is expected to grow from USD 466.58 Million in 2020 to USD 745.22 Million by the end of 2025.
2. The Global Vaccine Vials Market is expected to grow from EUR 409.11 Million in 2020 to EUR 653.42 Million by the end of 2025.
3. The Global Vaccine Vials Market is expected to grow from GBP 363.70 Million in 2020 to GBP 580.89 Million by the end of 2025.
4. The Global Vaccine Vials Market is expected to grow from JPY 49,796.60 Million in 2020 to JPY 79,534.06 Million by the end of 2025.
5. The Global Vaccine Vials Market is expected to grow from AUD 677.54 Million in 2020 to AUD 1,082.16 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Vaccine Vials to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Vaccine Vials Market studied across Multi Dose and Single Dose.
Based on Material, the Vaccine Vials Market studied across Glass and Polymer.
Based on Capacity, the Vaccine Vials Market studied across 10ml, 20ml, 2ml, 3ml, and 5ml.
Based on Application, the Vaccine Vials Market studied across Preventive Vaccine and Therapeutic Vaccine.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Vaccine Vials Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Vaccine Vials Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Vials Market including Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Cardinal Health, Inc., Catalent, Inc., Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd., JOTOP Glass, Nipro Corporation, Origin Pharmaceuticals Ltd, Pacific Vial Manufacturing Inc., Qorpak, Inc., Richland Glass Company, Inc., SCHOTT AG, Shandong Pharmaceutical Glass Co., Ltd., SiO2 Medical Products, Stevanato Group, Thermo Fisher Scientific Inc, and Vetter Pharma-Fertigung GmbH & Co. KG..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Vials Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Vaccine Vials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Vials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Vials Market?
4. What is the competitive strategic window for opportunities in the Global Vaccine Vials Market?
5. What are the technology trends and regulatory frameworks in the Global Vaccine Vials Market?
6. What are the modes and strategic moves considered suitable for entering the Global Vaccine Vials Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Vaccine Vials Market is expected to grow from USD 466.58 Million in 2020 to USD 745.22 Million by the end of 2025.
2. The Global Vaccine Vials Market is expected to grow from EUR 409.11 Million in 2020 to EUR 653.42 Million by the end of 2025.
3. The Global Vaccine Vials Market is expected to grow from GBP 363.70 Million in 2020 to GBP 580.89 Million by the end of 2025.
4. The Global Vaccine Vials Market is expected to grow from JPY 49,796.60 Million in 2020 to JPY 79,534.06 Million by the end of 2025.
5. The Global Vaccine Vials Market is expected to grow from AUD 677.54 Million in 2020 to AUD 1,082.16 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Vaccine Vials to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Vaccine Vials Market studied across Multi Dose and Single Dose.
Based on Material, the Vaccine Vials Market studied across Glass and Polymer.
Based on Capacity, the Vaccine Vials Market studied across 10ml, 20ml, 2ml, 3ml, and 5ml.
Based on Application, the Vaccine Vials Market studied across Preventive Vaccine and Therapeutic Vaccine.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Vaccine Vials Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Vaccine Vials Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Vials Market including Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Cardinal Health, Inc., Catalent, Inc., Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd., JOTOP Glass, Nipro Corporation, Origin Pharmaceuticals Ltd, Pacific Vial Manufacturing Inc., Qorpak, Inc., Richland Glass Company, Inc., SCHOTT AG, Shandong Pharmaceutical Glass Co., Ltd., SiO2 Medical Products, Stevanato Group, Thermo Fisher Scientific Inc, and Vetter Pharma-Fertigung GmbH & Co. KG..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Vials Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Vaccine Vials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Vials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Vials Market?
4. What is the competitive strategic window for opportunities in the Global Vaccine Vials Market?
5. What are the technology trends and regulatory frameworks in the Global Vaccine Vials Market?
6. What are the modes and strategic moves considered suitable for entering the Global Vaccine Vials Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Application Outlook
3.5. Material Outlook
3.6. Capacity Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for a large number of vaccines for the sales of vaccine vials
5.1.1.2. High prevalence of infectious diseases and rise of pharmaceutical industries
5.1.1.3. Growing initiatives from government and private organizations to advance vaccination
5.1.2. Restraints
5.1.2.1. Lack of healthcare infrastructure in developing countries such as Brazil, India, and China
5.1.3. Opportunities
5.1.3.1. Rising awareness of immunization among the people regarding the endemic diseases
5.1.3.2. Development of innovative vaccine administration methods
5.1.3.3. Attractive investment in Vaccine vial monitor (VVM)
5.1.4. Challenges
5.1.4.1. High-cost associated with the supply chain of vaccine vials
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL VACCINE VIALS MARKET, BY TYPE
6.1. Introduction
6.2. Multi Dose
6.3. Single Dose
7. GLOBAL VACCINE VIALS MARKET, BY MATERIAL
7.1. Introduction
7.2. Glass
7.3. Polymer
8. GLOBAL VACCINE VIALS MARKET, BY CAPACITY
8.1. Introduction
8.2. 10ml
8.3. 20ml
8.4. 2ml
8.5. 3ml
8.6. 5ml
9. GLOBAL VACCINE VIALS MARKET, BY APPLICATION
9.1. Introduction
9.2. Preventive Vaccine
9.3. Therapeutic Vaccine
10. AMERICAS VACCINE VIALS MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC VACCINE VIALS MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Anhui Huaxin Medicinal Glass Products Co., Ltd.
14.2. Berlin Packaging LLC
14.3. Cardinal Health, Inc.
14.4. Catalent, Inc.
14.5. Corning Inc.
14.6. DWK Life Sciences GmbH
14.7. Gerresheimer AG
14.8. Jinan Youlyy Industrial Co., Ltd.
14.9. JOTOP Glass
14.10. Nipro Corporation
14.11. Origin Pharmaceuticals Ltd
14.12. Pacific Vial Manufacturing Inc.
14.13. Qorpak, Inc.
14.14. Richland Glass Company, Inc.
14.15. SCHOTT AG
14.16. Shandong Pharmaceutical Glass Co., Ltd.
14.17. SiO2 Medical Products
14.18. Stevanato Group
14.19. Thermo Fisher Scientific Inc
14.20. Vetter Pharma-Fertigung GmbH & Co. KG.
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Application Outlook
3.5. Material Outlook
3.6. Capacity Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for a large number of vaccines for the sales of vaccine vials
5.1.1.2. High prevalence of infectious diseases and rise of pharmaceutical industries
5.1.1.3. Growing initiatives from government and private organizations to advance vaccination
5.1.2. Restraints
5.1.2.1. Lack of healthcare infrastructure in developing countries such as Brazil, India, and China
5.1.3. Opportunities
5.1.3.1. Rising awareness of immunization among the people regarding the endemic diseases
5.1.3.2. Development of innovative vaccine administration methods
5.1.3.3. Attractive investment in Vaccine vial monitor (VVM)
5.1.4. Challenges
5.1.4.1. High-cost associated with the supply chain of vaccine vials
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL VACCINE VIALS MARKET, BY TYPE
6.1. Introduction
6.2. Multi Dose
6.3. Single Dose
7. GLOBAL VACCINE VIALS MARKET, BY MATERIAL
7.1. Introduction
7.2. Glass
7.3. Polymer
8. GLOBAL VACCINE VIALS MARKET, BY CAPACITY
8.1. Introduction
8.2. 10ml
8.3. 20ml
8.4. 2ml
8.5. 3ml
8.6. 5ml
9. GLOBAL VACCINE VIALS MARKET, BY APPLICATION
9.1. Introduction
9.2. Preventive Vaccine
9.3. Therapeutic Vaccine
10. AMERICAS VACCINE VIALS MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC VACCINE VIALS MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Anhui Huaxin Medicinal Glass Products Co., Ltd.
14.2. Berlin Packaging LLC
14.3. Cardinal Health, Inc.
14.4. Catalent, Inc.
14.5. Corning Inc.
14.6. DWK Life Sciences GmbH
14.7. Gerresheimer AG
14.8. Jinan Youlyy Industrial Co., Ltd.
14.9. JOTOP Glass
14.10. Nipro Corporation
14.11. Origin Pharmaceuticals Ltd
14.12. Pacific Vial Manufacturing Inc.
14.13. Qorpak, Inc.
14.14. Richland Glass Company, Inc.
14.15. SCHOTT AG
14.16. Shandong Pharmaceutical Glass Co., Ltd.
14.17. SiO2 Medical Products
14.18. Stevanato Group
14.19. Thermo Fisher Scientific Inc
14.20. Vetter Pharma-Fertigung GmbH & Co. KG.
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. BRAZIL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. AUSTRALIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. CHINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. PHILIPPINES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. THAILAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. FRANCE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. GERMANY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. ITALY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. NETHERLANDS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. QATAR VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. RUSSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SPAIN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. GLOBAL VACCINE VIALS MARKET: SCORES
TABLE 135. GLOBAL VACCINE VIALS MARKET: BUSINESS STRATEGY
TABLE 136. GLOBAL VACCINE VIALS MARKET: PRODUCT SATISFACTION
TABLE 137. GLOBAL VACCINE VIALS MARKET: RANKING
TABLE 138. GLOBAL VACCINE VIALS MARKET: MERGER & ACQUISITION
TABLE 139. GLOBAL VACCINE VIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 140. GLOBAL VACCINE VIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 141. GLOBAL VACCINE VIALS MARKET: INVESTMENT & FUNDING
TABLE 142. GLOBAL VACCINE VIALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 143. GLOBAL VACCINE VIALS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. BRAZIL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. AUSTRALIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. CHINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. PHILIPPINES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. THAILAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. FRANCE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. GERMANY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. ITALY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. NETHERLANDS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. QATAR VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. RUSSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SPAIN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. GLOBAL VACCINE VIALS MARKET: SCORES
TABLE 135. GLOBAL VACCINE VIALS MARKET: BUSINESS STRATEGY
TABLE 136. GLOBAL VACCINE VIALS MARKET: PRODUCT SATISFACTION
TABLE 137. GLOBAL VACCINE VIALS MARKET: RANKING
TABLE 138. GLOBAL VACCINE VIALS MARKET: MERGER & ACQUISITION
TABLE 139. GLOBAL VACCINE VIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 140. GLOBAL VACCINE VIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 141. GLOBAL VACCINE VIALS MARKET: INVESTMENT & FUNDING
TABLE 142. GLOBAL VACCINE VIALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 143. GLOBAL VACCINE VIALS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL VACCINE VIALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VACCINE VIALS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 (USD MILLION)
FIGURE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 (USD MILLION)
FIGURE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL VACCINE VIALS MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL VACCINE VIALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2025
FIGURE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2025 (%)
FIGURE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025
FIGURE 23. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2025 (%)
FIGURE 26. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025
FIGURE 28. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 34. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2025
FIGURE 36. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 38. AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. ARGENTINA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. BRAZIL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CANADA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. MEXICO VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. UNITED STATES VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. AUSTRALIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. CHINA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. INDIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDONESIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. JAPAN VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. MALAYSIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. PHILIPPINES VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. THAILAND VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 61. FRANCE VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. GERMANY VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. ITALY VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. NETHERLANDS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. QATAR VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. RUSSIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SPAIN VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. GLOBAL VACCINE VIALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL VACCINE VIALS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 74. GLOBAL VACCINE VIALS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VACCINE VIALS MARKET, BY TYPE
FIGURE 1. GLOBAL VACCINE VIALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VACCINE VIALS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 (USD MILLION)
FIGURE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 (USD MILLION)
FIGURE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL VACCINE VIALS MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL VACCINE VIALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2025
FIGURE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2025 (%)
FIGURE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2025
FIGURE 23. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2025 (%)
FIGURE 26. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2025
FIGURE 28. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 34. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2025
FIGURE 36. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 38. AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. ARGENTINA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. BRAZIL VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CANADA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. MEXICO VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. UNITED STATES VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. AUSTRALIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. CHINA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. INDIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDONESIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. JAPAN VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. MALAYSIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. PHILIPPINES VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. THAILAND VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 61. FRANCE VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. GERMANY VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. ITALY VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. NETHERLANDS VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. QATAR VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. RUSSIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SPAIN VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. GLOBAL VACCINE VIALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL VACCINE VIALS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 74. GLOBAL VACCINE VIALS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VACCINE VIALS MARKET, BY TYPE
